Education
About Us
Working with TipRanks
Follow Us
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
RESEARCH TOOLSreports
Comparison Results
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$22.00
HK$8.73B
238.35
193.33%
―
Keymed Biosciences, Inc.
HK$44.60
HK$12.52B
―
28.90%
0 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$23.15
HK$13.33B
―
317.87%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shandong Boan Biotechnology Company., Limited. Class H
HK$12.44
HK$7.14B
80.52
35.36%
―
Performance Comparison
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
22.00
14.51
193.72%
HK:1672
Ascletis Pharma, Inc.
9.62
8.76
1018.60%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.82
1.87
47.34%
HK:2162
Keymed Biosciences, Inc.
44.60
10.00
28.90%
HK:2171
CARsgen Therapeutics Holdings Ltd.
23.15
18.28
375.36%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
12.44
3.16
34.05%